TipRanks
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
US Market
Want to see BMRN full AI Analyst Report?

BioMarin Pharmaceutical (BMRN) Ownership - Who Owns BioMarin Pharmaceutical?

2,466 Followers

BioMarin Pharmaceutical (BMRN) Ownership Overview

0.45%32.48%2.38%23.95%40.73%
2.38% Other Institutional Investors
23.95% ETFs
40.73% Public Companies and
Individual Investors
The ownership structure of BioMarin Pharmaceutical (BMRN) stock is a mix of institutional, retail, and individual investors. Approximately 58.82% of the company’s stock is owned by Institutional Investors, 0.45% is owned by Insiders, and 40.73% is owned by Public Companies and Individual Investors.
The ownership structure of BioMarin Pharmaceutical (BMRN) stock is a mix of institutional, retail, and individual investors. Approximately 34.86% of the company’s stock is owned by Institutional Investors, 0.45% is owned by Insiders, and 23.95% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 03, 2026
xxxxxxxxxxxxx
$1163678
May 11, 2026
xxxxxxxxxxxxx
$176682
Mar 12, 2026
xxxxxxxxxxxxx
$996744
Feb 26, 2026
xxxxxxxxxxxxx
$381901

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2026
xxxxxxxxxxxxx
$15730407
Jun 30, 2026
xxxxxxxxxxxxx
$849426895
Jun 30, 2026
xxxxxxxxxxxxx
$435819735
Jun 30, 2026
xxxxxxxxxxxxx
$743860

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
16,615,406Institution8.58%930,462,736
15,347,055Institution7.93%859,435,080
14,844,930Institution7.67%831,316,080
14,190,183Institution7.33%794,650,248
12,661,705Institution6.54%709,055,480
11,483,325Institution5.93%643,066,200
7,616,563Institution3.93%426,527,528
6,366,411Institution3.29%356,519,016
5,449,401Institution2.82%305,166,456
4,969,450Institution2.57%278,289,200

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
15,347,055Institution7.93%859,435,080
11,483,325Institution5.93%643,066,200
5,449,401Institution2.82%305,166,456
4,969,450Institution2.57%278,289,200
3,068,493Institution1.59%171,835,608
2,576,251Institution1.33%144,270,056
2,385,741Institution1.23%133,601,496
1,901,053Institution0.98%106,458,968
1,622,377Institution0.84%90,853,112
1,106,222Institution0.57%61,948,432

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
6,945,987Institution3.59%388,975,272
6,159,913Institution3.18%369,594,780
4,357,675Institution2.25%261,460,500
2,423,109Institution1.25%145,386,540
2,347,801Institution1.21%129,950,785
2,179,697Institution1.13%130,781,820
1,786,929Institution0.92%100,068,024
1,470,956Institution0.76%82,373,536
1,456,726Institution0.75%81,576,656
1,447,768Institution0.75%80,133,959

FAQ

Who Owns BioMarin Pharmaceutical (BMRN)?
According to the latest TipRanks data, approximately 2.38% of the company's stock is held by institutional investors, 0.45% is held by insiders, and 40.73% is held by retail investors.
    What percentage of BioMarin Pharmaceutical (BMRN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.38% of BioMarin Pharmaceutical (BMRN) stock is held by institutional investors.
      What percentage of BioMarin Pharmaceutical (BMRN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 40.73% of BioMarin Pharmaceutical (BMRN) stock is held by retail investors.
        Who owns the most shares of BioMarin Pharmaceutical (BMRN)?
        Vanguard owns the most shares of BioMarin Pharmaceutical (BMRN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.